» Articles » PMID: 16596304

Disruption of Circadian Coordination and Malignant Growth

Overview
Specialties Oncology
Public Health
Date 2006 Apr 6
PMID 16596304
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Altered circadian rhythms predicted for poor survival in patients with metastatic colorectal or breast cancer. An increased incidence of cancers has been reported in flying attendants and in women working predominantly at night. To explore the contribution of circadian structure to tumor growth we ablated the 24-h rest-activity cycle and markedly altered the rhythms in body temperature, serum corticosterone and lymphocyte count in mice by complete stereotaxic destruction of the suprachiasmatic nuclei (SCN) or by subjecting the mice to experimental chronic jet-lag. Such disruption of circadian coordination significantly accelerated malignant growth in two transplantable tumor models, Glasgow osteosarcoma and Pancreatic adenocarcinoma. The mRNA expression of clock genes per2 and reverb-alpha in controls displayed significant circadian rhythms in the liver (Cosinor, p=0.006 and p=0.003, respectively) and in the tumor (p=0.04 and p<0.001, respectively). Both rhythms were suppressed in the liver and in the tumor of jet lagged mice. This functional disturbance of molecular clock resulted in down regulation of p53 and overexpression of c-Myc, two effects which may favor cancer growth.

Conclusions: These results indicate that circadian system could play an important role in malignant growth control. This should be taken into consideration in cancer prevention and therapy.

Citing Articles

Circadian Rhythm Disruption in Cancer Survivors: From Oncogenesis to Quality of Life.

Kisamore C, Kisamore C, Walker 2nd W Cancer Med. 2024; 13(20):e70353.

PMID: 39463009 PMC: 11513439. DOI: 10.1002/cam4.70353.


Multimodal, Technology-Assisted Intervention for the Management of Menopause after Cancer Improves Cancer-Related Quality of Life-Results from the Menopause after Cancer (Mac) Study.

Donohoe F, OMeara Y, Roberts A, Comerford L, Valcheva I, Kearns U Cancers (Basel). 2024; 16(6).

PMID: 38539462 PMC: 10969475. DOI: 10.3390/cancers16061127.


The circadian clock as a potential biomarker and therapeutic target in pancreatic cancer.

Pourali G, Ahmadzade A, Arastonejad M, Pourali R, Kazemi D, Ghasemirad H Mol Cell Biochem. 2023; 479(5):1243-1255.

PMID: 37405534 DOI: 10.1007/s11010-023-04790-4.


Induction of Accelerated Aging in a Mouse Model.

Cai N, Wu Y, Huang Y Cells. 2022; 11(9).

PMID: 35563724 PMC: 9102583. DOI: 10.3390/cells11091418.


Disrupting circadian rhythms promotes cancer-induced inflammation in mice.

Lawther A, Phillips A, Chung N, Chang A, Ziegler A, Debs S Brain Behav Immun Health. 2022; 21:100428.

PMID: 35199050 PMC: 8851215. DOI: 10.1016/j.bbih.2022.100428.